CDA and colorectal carcinoma: Lesser evidence is available for TYMS, ENOSF1, MTHFR, ABCB1, and CDA; nevertheless, at least one study which includes hundreds of CRC patients has reported the significant association among the altered genes with adverse events and this information should not be disregarded.